Skip to content

Controlled randomised evaluation of group art therapy

Controlled Randomised Evaluation of group Art Therapy for people with personality disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74217860
Enrollment
50
Registered
2009-03-31
Start date
2009-04-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorder Mental and Behavioural Disorders Specific personality disorders

Interventions

Weekly group art psychotherapy for up to 24 months versus treatment as usual. Treatment as usual will conform to standards laid down in draft national guidance on the management of people with border
consideration of psychotropic medication, and the option of referral to crisis team and inpatient psychiatric treatment. The total duration of follow-up is 30 months.

Sponsors

Imperial College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Either sex, aged 18 to 70 years 2. Living in the London Boroughs of Kensington and Chelsea or Westminster 3. Have a primary diagnosis of personality disorder (PD) 4. Referred to the Waterview Centre 5. Have a diagnosis of PD confirmed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID-II)

Exclusion criteria

Exclusion criteria: 1. A primary diagnosis of a psychotic disorder, alcohol or drug dependence (those with a history of transient psychotic symptoms and non-dependent substance misuse will be included) 2. Already in receipt of art, music or another arts therapy 3. Currently being treated on a compulsory basis (under the Mental Health Act) 4. Unwilling to provide written informed consent to participate in the trial

Design outcomes

Primary

MeasureTime frame
Clinical Outcomes Routine Evaluation at 30 months

Secondary

MeasureTime frame
1. Mental health measured using the CORE at 6 and 18 months 2. Social functioning measures using the Social Functioning Questionnaire at 6, 18 and 30 months 3. Satisfaction with care using the 8-item Client Satisfaction Questionnaire at 6, 18 and 30 months 4. Quality of life using Euro-Qol at 6, 18 and 30 months 5. Frequency of suicidal acts and acts of deliberate self harm collected via a self-report questionnaire developed specifically for the study and measured at at 6, 18 and 30 months 6. Direct costs (healthcare and non-health care) and productivity costs will be calculated for at 18 and 30 months. Service utilisation data will be collected via a self-report questionnaire developed specifically for the study 7. Global Assessment of Functioning, a 100-point single item, observer-rated scale that rates functioning on a continuum from health to illness rated at 6, 18 and 30 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026